Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

BUY
$15.52 - $35.65 $127,620 - $293,149
8,223 Added 36.77%
30,584 $579,000
Q3 2021

Nov 04, 2021

BUY
$35.66 - $42.94 $220,450 - $265,455
6,182 Added 38.21%
22,361 $819,000
Q4 2020

Feb 09, 2021

BUY
$27.51 - $34.36 $103,024 - $128,678
3,745 Added 30.12%
16,179 $518,000
Q3 2020

Nov 10, 2020

SELL
$25.8 - $34.61 $78,586 - $105,422
-3,046 Reduced 19.68%
12,434 $402,000
Q2 2020

Aug 06, 2020

BUY
$17.65 - $28.05 $81,419 - $129,394
4,613 Added 42.45%
15,480 $427,000
Q3 2019

Nov 12, 2019

BUY
$17.84 - $22.69 $68,309 - $86,880
3,829 Added 54.4%
10,867 $194,000
Q4 2018

Feb 08, 2019

BUY
$23.09 - $37.69 $162,507 - $265,262
7,038 New
7,038 $154,000

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.